PAX5 fusion genes in t(7;9)(q11.2;p13) leukemia: A case report and review of the literature

Molecular Cytogenetics

Volumn 7, Issue 1, 2014, Pages

  Denk, Dagmar ^a   Bradtke, Jutta ^b   König, Margit ^a   Strehl, Sabine ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

AUTS2; B cell precursor acute lymphoblastic leukemia; der(9)t(7; 9)(q11.2; p13); ELN; PAX5 fusions; POM121; t(7; 9)(q11.2; p13)

Indexed keywords

TRANSCRIPTION FACTOR PAX5;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AUTS2 GENE; CHILD; CHROMOSOME 7Q; CHROMOSOME PAINTING; CLINICAL ARTICLE; CYTOGENETICS; ELN GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; KARYOTYPING; LEUKEMOGENESIS; MALE; POM 121 GENE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHOOL CHILD; TRANSCRIPTION FACTOR PAX5 GENE; YOUNG ADULT;

EID: 84896736590     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-7-13     Document Type: Review

References (15)

1. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Nebral K, Denk D, Attarbaschi A, Konig M, Mann G, Haas OA, Strehl S, Leukemia 2009 23 134 143 10.1038/leu.2008.306 19020546
2. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, Dastugue N, Brousset P, Blood 2007 109 3417 3423 10.1182/blood-2006-05-025221 17179230
3. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E, Kearney L, Biondi A, Cancer Res 2001 61 4666 4670 11406533
4. Wide diversity of PAX5 alterations in B-ALL: a groupe francophone de cytogenetique hematologique study. Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, et al. Blood 2010 115 3089 3097 10.1182/blood-2009-07-234229 20160164
5. Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, et al. Proc Natl Acad Sci U S A 2008 105 11921 11926 10.1073/pnas.0711039105 18697940
6. Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia. Lee ST, Ji Y, Kim HJ, Ki CS, Jung CW, Kim JW, Kim SH, Leuk Res 2012 36 418 421 10.1016/j.leukres.2011.12.021 22309891
7. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. Nature 2007 446 758 764 10.1038/nature05690 17344859
8. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA, Tasian SK, Loh ML, Su X, Liu W, et al. PNAS Supplements 2009 106 9414 9418 10.1073/pnas.0811761106
9. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia. Coyaud E, Struski S, Dastugue N, Brousset P, Broccardo C, Bradtke J, Leuk Res 2010 34 323 e325 10.1016/j.leukres.2010.07.035 20723977
10. PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia. Denk D, Nebral K, Bradtke J, Pass G, Moricke A, Attarbaschi A, Strehl S, Leuk Res 2012 36 178 e181 10.1016/j.leukres.2012.04.015 22578776
11. Mitelman database of chromosome aberrations and gene fusions in cancer. Mitelman F, Johansson B, Mertens F, 2013 http://cgap.nci.nih.gov/Chromosomes/ Mitelman
12. Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH, Cancer 2003 98 2715 2722 10.1002/cncr.11841 14669294
13. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia. van Zutven LJ, van Drunen E, de Bont JM, Wattel MM, Den Boer ML, Pieters R, Hagemeijer A, Slater RM, Beverloo HB, Leukemia 2005 19 1281 1284 10.1038/sj.leu.2403769 15843818
14. Sex ratios and the risks of haematological malignancies. Cartwright RA, Gurney KA, Moorman AV, Br J Haematol 2002 118 1071 1077 10.1046/j.1365-2141. 2002.03750.x 12199787
15. t(7;9)(q11;p13). Bousquet M, Dastugue N, Brousset P, 2007 http://AtlasGeneticsOncology.org/Anomalies/t0709q11p13ID1195.html